We investigated the performance of dried blood spots (DBS) in hepatitis C virus (HCV) diagnosis using modified commercial tests. Paired DBS and serum samples were collected from 200 patients: 100 patients with anti-HCV antibodies (anti-HCV), including 62 patients with detectable serum HCV RNA, and 100 patients without anti-HCV. The DBS sample consisted of three drops of approximately 50 L of whole blood applied to a paper card, which was then stored at ؊20°C within 48 hours of collection. Using the Ortho HCV 3.0 enzyme-linked immunosorbent assay kit on DBS, we observed both a specificity and sensitivity of 99% in detecting anti-HCV. HCV RNA was detected on DBS in 60/62 (97%) patients with detectable serum HCV RNA, which was then successfully quantified in 55 samples (89%) using the Cobas TaqMan HCV test. A good correlation was observed between the DBS HCV RNA concentration and the serum level (r 2 ؍ 0.95; P < 0.001). HCV genotyping was successfully performed on DBS samples, with a full concordance between the 14 paired DBS and serum samples (genotypes 1-4). Conclusion: This study presents DBS as a reliable alternative to serum specimens for detecting anti-HCV, quantifying HCV RNA and genotyping HCV. DBS may increase the opportunities for HCV testing and treatment follow-up in hard-to-reach individuals. (HEPATOLOGY 2010;51:752-758.) H epatitis C virus (HCV) infection is currently underdiagnosed, leaving many individuals unaware of their infection status. Some population groups, such as sex workers, the homeless, prisoners, or other institutionalized individuals, have a higher prevalence of HCV infection than the general population. [1][2][3] However, HCV testing in these groups is limited by the poor acceptability or feasibility of venipuncture. Collecting capillary blood spots on filter paper requires less staff training, is less invasive, involves smaller blood volumes, and is ideal for high-risk patients with damaged veins, such as intravenous drug users. 4 In addition, this technique can reduce the cost of HCV testing by simplifying sample collection, processing (no centrifugation), storage, and shipment. Many studies have already demonstrated the value of dried blood spots (DBS) for the serological and molecular diagnosis of human immunodeficiency virus. [5][6][7][8][9][10][11] Routine screening for HCV infection relies on detecting antibodies against HCV (anti-HCV) using highly sensitive second-or third-generation enzyme immunoassay. DBS have been used to detect anti-HCV among intravenous drug users, prisoners and childbearing women. 12-17 However, the diagnosis of acute or chronic infection also requires the detection of HCV RNA by polymerase chain reaction (PCR). 18,19 Likewise, when recent HCV infection is suspected or the patient is immunocompromised, then the sample should be referred for PCR. Samples with a low screening signal-to-cutoff ratio may also need confirmation with these more specific recombinant immunoblot assays. 20,21 In this study, we have investigated both anti-HCV and HCV RNA detecti...
The recent Zika virus (ZIKV) epidemic has highlighted the poor knowledge on its physiopathology. Recent studies showed that ZIKV of the Asian lineage, responsible for this international outbreak, causes neuropathology in vitro and in vivo. However, two African lineages exist and the virus is currently found circulating in Africa. The original African strain was also suggested to be neurovirulent but its laboratory usage has been criticized due to its multiple passages. In this study, we compared the French Polynesian (Asian) ZIKV strain to an African strain isolated in Central African Republic and show a difference in infectivity and cellular response between both strains in human neural stem cells and astrocytes. Consistently, this African strain led to a higher infection rate and viral production, as well as stronger cell death and anti-viral response. Our results highlight the need to better characterize the physiopathology and predict neurological impairment associated with African ZIKV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.